Report Analyzes Key Controversies In Multiple Sclerosis Treatment

Armen Hareyan's picture
Advertisement

Multiple Sclerosis

Advertisement

MedPredict Market Research has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for MS therapies.

In this report, entitled "MedPredict Thought Leader Insight & Analysis: Multiple Sclerosis," physician experts discuss the key controversies emerging from ECTRIMS (European Committee for Treatment and Research in MS) 2007, including:

Advertisement